Mu Opioid receptor

The μ opioid receptors (MOR) are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. The prototypical μ receptor agonist is the opium alkaloid morphine; μ (mu) refers to morphine. Certainother opiates, notably heroin, are prodrugs that are metabolized into morphine. PBB_Summary
section_title =
summary_text =

Types

There are three known variants of the μ opioid receptor.cite journal |author=Dortch-Carnes J, Russell K |title=Morphine-stimulated nitric oxide release in rabbit aqueous humor |journal=Exp. Eye Res. |volume=84 |issue=1 |pages=185–90 |year=2007 |pmid=17094965 |doi=10.1016/j.exer.2006.09.014 |url=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1766947]

More is known about the μ₁ opioid receptor than is known about the other types, but some information does exist. TRIMU 5 is a selective agonist of the μ₂ receptor.cite journal |author=Eisenberg RM |title=TRIMU-5, a μ₂-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis |journal=Pharmacol. Biochem. Behav. |volume=47 |issue=4 |pages=943–6 |year=1994 |pmid=8029266 |doi=]

In 2003, a μ₃ variant was described,cite journal |author=Cadet P, Mantione KJ, Stefano GB |title=Molecular identification and functional expression of μ₃, a novel alternatively spliced variant of the human μ opiate receptor gene |journal=J. Immunol. |volume=170 |issue=10 |pages=5118–23 |year=2003 |pmid=12734358 |doi=] which was responsive to opiate alkaloids but not opioid peptides.cite journal |author=Stefano GB |title=Endogenous morphine: a role in wellness medicine |journal=Med. Sci. Monit. |volume=10 |issue=6 |pages=ED5 |year=2004 |pmid=15173675 |doi=]

Location

They can exist either presynaptically or postsynaptically depending upon cell types.

The μ-receptors exist mostly presynaptically in the periaqueductal gray region, and in the superficial dorsal horn of the spinal cord (specifically the substantia gelatinosa of Rolando). Other areas where μ-receptors have been located include the external plexiform layer of the olfactory bulb, the nucleus accumbens, in several layers of the cerebral cortex and in some of the nuclei of the amygdala, as well as the nucleus of the solitary tract.

μ receptors are also found in the intestinal tract. This causes constipation, a major side effect of μ agonists, due to inhibition of peristaltic action.

Activation

MOR can mediate acute changes in neuronal excitability via "disinhibition" of presynaptic release of GABA (see works from Charles Chavkin and Roger Nicoll). Activation of the MOR leads to different effects on dendritic spines depending upon the agonist, and may be an example of functional selectivity at the μ receptor (see works from Dezhi Liao and Horace Loh). The physiological and pathological roles of these two distinct mechanisms remain to be clarified. Perhaps, both might be involved in opioid addiction and opioid-induced deficits in cognition.

Activation of the μ receptor by an agonist such as morphine causes analgesia, sedation, slightly reduced blood pressure, itching, nausea, euphoria, decreased respiration, miosis (constricted pupils) and decreased bowel motility often leading to constipation. Some of these side effects, such as sedation, euphoria and decreased respiration, tend to lessen with continued use as tolerance develops. Analgesia, miosis and reduced bowel motility tend to persist; little tolerance develops to these effects.

Tolerance and overdoses

Opioid overdoses kill through apnea and fatal hypoxia, oftenaggravated by simultaneous use of alcohol, benzodiazepines or barbiturates.However, substantial tolerance to respiratory depression develops quickly and tolerant individuals can easily withstand large doses fatal to opioid naïve individuals (an example of Mithridatism).Less commonly, massive overdoses have been known to cause circulatory collapse.

Tolerance to respiratory depression is lost just as quickly during withdrawal. Many, if not most fatal overdoses occur in addicts who take their usual doses after being in withdrawal long enough to lose their tolerance to respiratory depression.

Opioid overdoses can be rapidly reversed with any of several opioid antagonists: naloxone, or naltrexone, differing primarily in their duration of action and potency. While commonly referred to as antagonists, and when used to treat an overdose they do appear to function as such, naloxone & naltrexone are inverse agonists.

References

External links

* [http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2405 IUPHAR GPCR Database - μ opioid receptor]
*

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = no